1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Japan Lifeline Co., Ltd.
  6. News
  7. Summary
    7575   JP3754500001

JAPAN LIFELINE CO., LTD.

(7575)
  Report
Delayed Japan Exchange  -  05/20 02:00:00 am EDT
965.00 JPY    0.00%
05/11Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Second Quarter and Year Ending March 31, 2023
CI
05/11Japan Lifeline Co., Ltd. Announces Cash Dividend for the Year Ended March 31, 2022
CI
05/11Japan Lifeline Co., Ltd. Provides Year-End Cash Dividend Guidance for the Fiscal Year Ending March 31, 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Japan Lifeline : Summary Report of Consolidated Financial Results for the Nine Months Ended December 31, 2021

01/28/2022 | 01:16am EDT

Summary Report of Consolidated Financial Results for the Nine months Ended December 31, 2021 [Japan GAAP]

January 28, 2022

Company name

: Japan Lifeline Co., Ltd.

Code No.

: 7575

Stock Exchange Listing

: Tokyo Stock Exchange, 1st Section

URL

: https://www.jll.co.jp

Representative

: Keisuke Suzuki, President and CEO

Contact person

: Kenji Yamada, Senior Vice President Corporate Administration Headquarters

TEL

: +81-3-6711-5200

Scheduled date to file the Quarterly Securities Report

: February 10, 2022

Scheduled date to commence dividend payment

: -

Supplementary documents to the financial results for the period

: Available

Presentation on quarterly results

: Not available

(Amounts are rounded down to million yen)

1. Consolidated Financial Results for the Nine months Ended December 31, 2021 (April 1, 2021 to December 31, 2021)

(1) Consolidated operating results

(% indicates year-on-year changes)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Nine

months

ended

39,009

1.8

7,504

(0.1)

7,509

3.6

5,522

-

December 31, 2021

Nine

months

ended

38,328

0.8

7,511

(1.4)

7,248

(9.0)

248

(95.7)

December 31, 2020

(Note)

Comprehensive income: Nine months ended December 31, 2021

: 5,770 million yen;

- %

Nine months ended December 31, 2020

: 415 million yen;

(92.9)%

Earnings per share

Diluted earnings

per share

Yen

Yen

Nine months ended December 31, 2021 Nine months ended December 31, 2020

68.69-

3.09-

  1. Consolidated financial position

Total assets

Net assets

Equity ratio

Millions of yen

Millions of yen

%

As of December 31, 2021

70,722

53,134

75.1

As of March 31, 2021

72,962

51,304

70.3

(Reference) Shareholders' equity:

As of December 31, 2021 : 53,134 million yen

As of March 31, 2021

: 51,304 million yen

- 1 -

2.

Dividends

Cash dividends per share

1Q End

2Q End

3Q End

Year-End

Total

Yen

Yen

Yen

Yen

Yen

Year ended March 31, 2021

-

0.00

-

49.00

49.00

Year ending March 31, 2022

-

0.00

-

Year ending March 31, 2022 (forecast)

38.00

38.00

(Note) Revisions to cash dividends forecast most recently announced : None

The year-end dividend of 49 yen for the year ended March 31, 2021 consists of an ordinary dividend of 29 yen and a commemorative dividend of 20 yen.

3. Forecast of Consolidated Financial Results for the Year Ending March 31, 2022 (April 1, 2021 to March 31, 2022)

(% represents change from the previous year)

Net sales

Operating profit

Ordinary profit

Profit attributable to

Earnings

owners of parent

per share

Millions of

%

Millions of

%

Millions of

%

Millions of

%

Yen

yen

yen

yen

yen

Year ending March

52,979

3.3

10,625

2.5

10,682

1.5

7,567

278.3

94.11

31, 2022

(Note) Revisions to the forecast of consolidated financial results most recently announced

: None

* Notes

  1. Changes in significant subsidiaries during the period (change in specified subsidiaries resulting in scope of consolidation): None
  2. Application of specific accounting treatments for the preparation of the consolidated quarterly financial statement: None
  3. Changes in accounting policies, changes in accounting estimates and restatements

(i)

Changes in accounting policies due to the revision of accounting standards

: Yes

(ii)

Changes in accounting policies other than (i)

: None

(iii)

Changes in accounting estimates

: None

(iv)

Restatement

: None

  1. Number of issued shares outstanding (common stock)
  1. Number of issued shares at the end of the period (including treasury stock):

Nine months ended December 31, 2021

: 85,419,976

shares

Year ended March 31, 2021

: 85,419,976

shares

  1. Number of shares held as treasury stock at the end of the period:

Nine months ended December 31, 2021

: 4,999,541

shares

Year ended March 31, 2021

: 5,050,861

shares

  1. Average number of issued shares outstanding during the period, after deducting shares held as treasury stock:

Nine months ended December 31, 2021

: 80,408,397

shares

Nine months ended December 31, 2020

: 80,309,526

shares

(Notes) 1 The Company has adopted a BIP (Board Incentive Plan) trust, assuming the number of shares held by the trust are included

in the number of treasury stock of "(4) Number of issued shares outstanding (common stock)".

2 The Company has adopted the trust-type employee stock ownership incentive plan (E-Ship), which was terminated on July

29, 2021. The Company's shares held by the trust were treated as treasury stock in "(4) Number of issued shares outstanding

(common stock)".

*This Summary Report is out of scope for quarterly review by the external auditors.

*Explanation for the appropriate use of forecast of the consolidated financial results and other special notes.

Any forward-looking statements in the summary report, such as results forecasts, are based on the information currently available to the

Company and certain assumptions that the Company deems to be reasonable at the time this report was prepared. Actual results may

differ significantly from the forecasts due to various factors.

- 2 -

Disclaimer

JLL - Japan Lifeline Co. Ltd. published this content on 28 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 January 2022 06:15:05 UTC.


© Publicnow 2022
All news about JAPAN LIFELINE CO., LTD.
05/11Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Second Quarter and Year End..
CI
05/11Japan Lifeline Co., Ltd. Announces Cash Dividend for the Year Ended March 31, 2022
CI
05/11Japan Lifeline Co., Ltd. Provides Year-End Cash Dividend Guidance for the Fiscal Year E..
CI
05/04Japan Lifeline Spends Over $4 Million on Share Repurchase in April
MT
05/02JAPAN LIFELINE : Announces Results of Acquisition of Own Shares
PU
04/03Japan Lifeline Spends $4 Million on Share Repurchase in March
MT
04/01JAPAN LIFELINE : Announces Results of Acquisition of Own Shares
PU
03/31JAPAN LIFELINE : Announces a New Appointment of Operating Officer
PU
03/31Japan Lifeline Co., Ltd. Appoints Shigeki Kitayama as Operating Officer
CI
03/22Japan Lifeline to Exclusively Distribute Avenir Coil System in Japan; Shares Up 3%
MT
More news
Analyst Recommendations on JAPAN LIFELINE CO., LTD.
More recommendations
Financials
Sales 2022 52 564 M 413 M 413 M
Net income 2022 7 597 M 59,7 M 59,7 M
Net cash 2022 7 058 M 55,4 M 55,4 M
P/E ratio 2022 10,4x
Yield 2022 3,94%
Capitalization 77 016 M 605 M 605 M
EV / Sales 2022 1,33x
EV / Sales 2023 1,21x
Nbr of Employees 1 167
Free-Float 68,3%
Chart JAPAN LIFELINE CO., LTD.
Duration : Period :
Japan Lifeline Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JAPAN LIFELINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 965,00 JPY
Average target price 1 352,00 JPY
Spread / Average Target 40,1%
EPS Revisions
Managers and Directors
Keisuke Suzuki President & Representative Director
Takeshi Egawa Manager-Accounting & Finance
Yumiko Hoshiba Manager-General Affairs
Kenji Yamada Managing Director & GM-Administration
Fumihiro Sasaki Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
JAPAN LIFELINE CO., LTD.-11.95%605
STRYKER CORPORATION-13.81%87 165
SMITH & NEPHEW PLC-2.74%13 696
INSPIRE MEDICAL SYSTEMS, INC.-25.36%4 738
AXONICS, INC.-11.95%2 321
DOUBLE MEDICAL TECHNOLOGY INC.-35.99%2 014